Piramal Pharma
29 March, 2024 12:52 BSE: 543635
NSE: PPLPHARMAISIN: INE0DK501011
Start SIP in Piramal Pharma
Start SIPPiramal Pharma Performance
Day Range
- Low 123
- High 129
52 Week Range
- Low 62
- High 149
- Open Price123
- Previous Close122
- Volume5924097
Piramal Pharma Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 1,024 | 994 | 846 | 1,055 |
Operating Expenses Qtr Cr | 899 | 908 | 830 | 965 |
Operating Profit Qtr Cr | 126 | 86 | 17 | 90 |
Depreciation Qtr Cr | 52 | 51 | 50 | 53 |
Interest Qtr Cr | 17 | 28 | 34 | 34 |
Tax Qtr Cr | 15 | 19 | -8 | 24 |
Net Profit Qtr Cr | 74 | 77 | -33 | 42 |
Piramal Pharma Technicals
EMA & SMA
Current Price
₹128.9
6.55 (5.35%)
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹124.59
- 50 Day
- ₹128.47
- 100 Day
- ₹126.12
- 200 Day
- ₹119.36
- 20 Day
- ₹124.11
- 50 Day
- ₹132.45
- 100 Day
- ₹130.63
- 200 Day
- ₹114.22
Piramal Pharma Resistance and Support
PIVOT
₹127.17
Resistance | |
---|---|
First Resistance | 131.13 |
Second Resistance | 133.37 |
Third Resistance | 137.33 |
RSI | 54.55 |
MFI | 52.15 |
MACD Single Line | -3.67 |
MACD | -2.80 |
Support | |
---|---|
First Resistance | 124.93 |
Second Resistance | 120.97 |
Third Resistance | 118.73 |
Piramal Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 6,319,040 | 248,906,986 | 39.39 |
Week | 5,986,314 | 268,426,297 | 44.84 |
1 Month | 5,152,105 | 274,298,063 | 53.24 |
6 Month | 7,466,432 | 343,754,518 | 46.04 |
Piramal Pharma Result Highlights
Piramal Pharma Synopsis
NSE-Medical-Diversified
Piramal Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3443.22 Cr. and Equity Capital is Rs. 1193.32 Cr. for the Year ended 31/03/2023. Piramal Pharma Ltd. is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592.Market Cap | 17,054 |
Sales | 3,919 |
Shares in Float | 86.00 |
No of funds | 204 |
Yield |
Book Value | 2.98 |
U/D Vol ratio | 1 |
LTDebt / Equity | 11 |
Alpha | 0.12 |
Beta | 1.24 |
Piramal Pharma
Owner Name | Dec-23 | Sep-23 | Aug-23 | Jun-23 |
---|---|---|---|---|
Promoters | 35.02% | 35.02% | 35.02% | 34.79% |
Mutual Funds | 6.28% | 3.8% | 3.62% | 0.91% |
Insurance Companies | 2.88% | 3.8% | 3.82% | 4.21% |
Foreign Portfolio Investors | 14.47% | 14.33% | 14.18% | 15.01% |
Financial Institutions/ Banks | ||||
Individual Investors | 15.57% | 16.95% | 16.81% | 16.77% |
Others | 25.78% | 26.1% | 26.55% | 28.31% |
Piramal Pharma Management
Name | Designation |
---|---|
Mrs. Nandini Piramal | Chairperson |
Mr. Peter DeYoung | Executive Director |
Mr. Vivek Valsaraj | Executive Director & CFO |
Mr. Neeraj Bharadwaj | Non Executive Director |
Mr. Nathalie Leitch | Non Executive Director |
Mr. S Ramadorai | Independent Director |
Mr. Jairaj Purandare | Independent Director |
Mr. Peter Stevenson | Independent Director |
Mr. Sridhar Gorthi | Independent Director |
Ms. Vibha Paul Rishi | Independent Director |
Piramal Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Piramal Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-01-30 | Quarterly Results | |
2023-10-27 | Quarterly Results | |
2023-08-03 | Quarterly Results | |
2023-05-24 | Audited Results | |
2023-02-08 | Quarterly Results & Rights issue |
Piramal Pharma FAQs
What is Share Price of Piramal Pharma ?
Piramal Pharma share price is ₹128 As on 29 March, 2024 | 12:38
What is the Market Cap of Piramal Pharma ?
The Market Cap of Piramal Pharma is ₹17053.8 Cr As on 29 March, 2024 | 12:38
What is the P/E ratio of Piramal Pharma ?
The P/E ratio of Piramal Pharma is -511.5 As on 29 March, 2024 | 12:38
What is the PB ratio of Piramal Pharma ?
The PB ratio of Piramal Pharma is 2.5 As on 29 March, 2024 | 12:38